Navigation Links
American Oriental Bioengineering Completes Two Acquisitions
Date:10/21/2008

on.

AOBO entered into an acquisition agreement to acquire Nuo Hua for approximately $39.5 million in cash after terminating a previously announced, non-binding Letter of Intent to acquire another company in the distribution industry in China. Management believes that acquiring Nuo Hua instead of the other company was a more efficient use of cash, allowed AOBO to acquire compelling distribution assets at a lower price, and also allowed AOBO to conserve cash for future acquisitions and growth plans.

GuangXi HuiKe Research and Development Company Ltd.

GuangXi HuiKe ("GHK") is engaged in pharmaceutical research and product development leading to SFDA approval and expedient product launches in China. The Company employs 22 professionals and provides research and development through innovative technology, raw material selection, extraction and production of pharmaceutical products. The Company also has a dedicated focus on navigating the new drug approval and launch process in China, and has completed over 60 development projects over the past few years, including obtaining new drug production licenses, approvals for clinical trials, and technology patents. AOBO acquired GHK for $13.6 million in cash.

The monetary exchange rate used for these transactions was US$1.00: RMB 6.83.

Conference Call

The Company will hold a conference call at 8:00 am ET (8:00 pm China Time) on Wednesday, October 22, 2008, to discuss the acquisitions of Nuo Hua and GHK. Listeners may access the call by dialing the following numbers: United States toll free: +1-866-316-1368, International: +1-913-312-0845, Northern China toll free: +10-800-714-0970, Southern China toll free: +10-800-140-0945. A webcast will also be available on the Company's website at http://www.bioaobo.com . A replay of the call will be available through October 29, 2008. Listeners may access the replay by dialing 1-888-203-1112 or 1-719
'/>"/>

SOURCE American Oriental Bioengineering, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Research and Markets ( ... Jain PharmaBiotech,s new report "Nanobiotechnology Applications, ... An increasing use of ... is anticipated. Nanotechnology will be applied at ... formulations for optimal delivery to diagnostic applications ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... , September 2, 2015 BiondVax Pharmaceuticals ... the National Institute of Allergy and Infectious Diseases (NIAID), part ... Department of Health and Human Services (HHS), to launch a ... the United States in the 2015-16 timeframe. The ... candidate, Multimeric-001 (M-001), as a primer vaccine, which would be ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... SHANGHAI, June 21 /PRNewswire-Asia/ -- WuXi ... pharmaceutical, biotechnology, and medical device research and,development outsourcing company ... that Wei-Min Chang has been appointed Vice President of,Operations ... located in the Jinshan chemical industry zone of Shanghai. ...
... Inc. announced on June 16, 2009, that the Company ... each filed a voluntary petition for reorganization under chapter ... United States Bankruptcy Court for the District of Delaware ... to continue to manage and operate their business as ...
... Corp. (TSX, FSE: HBP) today announced that Dr. Heman ... be presenting a scientific poster describing L-DOS47 analytical method ... Scientists ("AAPS") National Biotechnology Conference, which runs from June ... Trade Center in Seattle, Washington. , ...
Cached Biology Technology:WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 2Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 4Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 5
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... , 31 de julho de 2015 ... www.icg-10.org ) será realizada pela BGI de 22-25 de ... . A conferência está celebrando seu 10 ... 2006, a ICG se tornou uma das reuniões mais ... dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... de julio de 2015 La 10 th ... por medio de BGI del 22 al 25 de octubre de ... Este año, la conferencia celebra su décimo aniversario. Desde ... en una de las reuniones anuales más influyentes del mundo ... reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... regularly vomiting hairballs or refusing to eat probably isn,t being ... There is a good chance that the cat is acting ... environment, new research suggests. Healthy cats were just as ... and leave waste outside their litter box in response to ...
... Salt Lake City, December 30, 2010Officials at Huntsman ... that the National Cancer Institute (NCI) has renewed its ... recognizes the outstanding cancer research conducted at HCI, which ... West and is the only NCI-designated Cancer Center within ...
... can result in long waiting times for seriously ill ... illnesses for the next available treatment. In this edition ... Int 2010; 107[50]: 892𔃆), Michael Christ and his ... assessment of emergency patients. Triage provides reliable methods ...
Cached Biology News:Even healthy cats act sick when their routine is disrupted 2Even healthy cats act sick when their routine is disrupted 3Even healthy cats act sick when their routine is disrupted 4Even healthy cats act sick when their routine is disrupted 5National Cancer Institute renews Cancer Center designation for Huntsman Cancer Institute 2
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determin interaction of your protein with Echelons lipids...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Biology Products: